Evelo Biosciences, Inc., a clinical stage biotechnology company developing a novel platform of orally delivered medicines acting on the small intestinal axis, SINTAX, announced the appointment of Marella Thorell as Chief Financial Officer, effective September 1, 2022.
July 18, 2022
· 6 min read